QENC - QENC STOCK NEWS

KRTL Holding Group has welcomed Mr. David Beling as a Strategic Advisor, bringing over 50 years of mining experience. A graduate in Mining Engineering, Beling has contributed to various mining projects and companies, including Bullfrog Gold Corp and Geovic Mining Corp. His extensive background includes overseeing the development of significant mining operations and raising substantial capital. Beling expressed enthusiasm about enhancing KRTL's business model and production plans, indicating a promise for growth and profitability.

KRTL International Corp. (OTC: KRTL) has formed a strategic alliance with Cannabis Global, Inc. (OTC: CBGL) to enhance infusion technologies in the hemp and cannabis markets. This collaboration aims to develop water-soluble formulations and proprietary delivery methods for a variety of products. The partnership intends to leverage shared R&D and marketing strategies, allowing both companies to potentially access international markets, particularly in Asia. KRTL plans to showcase these innovations at the MJ BIZ CON event in November 2022.

KRTL International Corp. has partnered with ICANN Ventures and Yeungnam University to enhance the Korean Cannabis industry through professional education. The collaboration will launch a CBD Training Academy offering specialized courses and certification programs, starting October 2022. This initiative aims to educate a diverse group of professionals within the cannabis sector, responding to the evolving landscape in South Korea where medical cannabis use is becoming more accepted. The program emphasizes sustainable growth and aims to equip students with in-depth knowledge in the cannabis ecosystem.

KRTL Holding Group (OTC: KRTL) announced a strategic alliance with ENTEXS Corporation, focusing on advanced extraction technology for cannabis and psilocybin. They will showcase their mobile extraction unit at MJBizCon Las Vegas in November 2022. The partnership includes R&D support for psilocybin extraction and plans to introduce psilocybin products in Oregon's newly legalized market in early 2023. KRTL is also advancing cannabis technology in South Korea, specifically THC remediation, with a focus on maintaining CBD concentrations while retaining regulatory compliance.

KRTL Holding Group, Inc. (OTC: KRTL) announced a strategic alliance with Entexs Corporation and Iron Sight Industries to deploy a mobile extraction plant for cannabis and hemp. This state-of-the-art system can extract up to 2,000 pounds of biomass per day and is engineered for remote operation. KRTL aims to launch operations in several states, tapping into a potential annual market of over $200 million from THC distillate and isolate production. The collaboration enhances KRTL's operational flexibility and stakeholder risk management.

KRTL Holding Group, Inc. has made significant strides since its inception, including acquiring the KRTL stock symbol (OTCMKTS: KRTL) and canceling 6,676,668 common shares. The company focuses on strategic growth, having recruited 27 executives and advisors, and established in-house counsel. Its subsidiary, KRTL Biotech, is advancing in cannabis and hemp extraction technology and has approvals for psilocybin and CBD trials in South Korea. KRTL International, led by CEO Kai Kim, is positioned as a Foreign Advisor to a Special Free Zone in Korea, enhancing opportunities in the cannabis sector.

KRTL Holding Group, Inc. (OTC: KRTL) announced the appointment of Dr. Malcolm A. Leissring as Chief Science Officer of its subsidiary, KRTL Biotech, Inc. Dr. Leissring, a leading neuroscientist, specializes in Alzheimer’s disease and diabetes, with a proven track record in drug discovery. He has published over 60 scientific works and has received numerous grants from prestigious organizations. This strategic hire is aimed at enhancing KRTL's research capabilities and strengthens its position in biotech innovation as the company continues to explore new market opportunities.

KRTL Holding Group, Inc. (OTC: KRTL), previously QUEENCH, Inc. (OTC: QENC), announces the approval of its name and ticker change effective July 25, 2022. This strategic shift aims to enhance its brand and align with its business model, fostering better relationships with stakeholders. The name change does not affect existing shareholder stock, with shares remaining the same. CEO Cesar Herrera emphasized that the name KRTL reflects the company's vision and integrates technologies with logistics. More information is available on their website.

Queench, Inc. (OTC Pink: QENC) announced a change of control with KRTL Biotech, Inc., granting KRTL voting control via Special Series A Preferred stock. New leadership appointments include Kai Kim as CEO, Cesar Herrera as COO, and Tony Hernandez as Treasurer/Secretary. The firm is shifting its business model toward biotechnology and plans to seek a name and symbol change to reflect this transition. Management aims to enhance market capitalization and shareholder value through forthcoming strategies.